Skip to content
drillr.ai
Sign up

DTIL

Precision BioSciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$7.47
+1.36%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+15.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 5, 2026Pire Shari Lisa · directorA-Award20,979$0.00
Jun 5, 2026Frankel Stanley · directorA-Award20,979$0.00
Jun 5, 2026Brown Melinda · directorA-Award20,979$0.00
Jun 5, 2026Buehler Kevin · directorA-Award20,979$0.00
Jun 5, 2026Germano Geno J · directorA-Award20,979$0.00
May 22, 2026Brown Melinda · directorM-Exempt21,000$0.00
May 22, 2026Frankel Stanley · directorM-Exempt21,000$0.00
May 22, 2026Buehler Kevin · directorM-Exempt21,000$0.00
May 22, 2026Germano Geno J · directorM-Exempt21,000$0.00
May 22, 2026Pire Shari Lisa · directorM-Exempt21,000$0.00
Feb 19, 2026Scimeca Dario · officer: General Counsel and SecretarySale4,925$3.84
Feb 19, 2026Kelly John Alexander · officer: Chief Financial OfficerSale8,149$3.84
Feb 19, 2026Kelly John Alexander · officer: Chief Financial OfficerM-Exempt27,584$0.00
Feb 19, 2026Scimeca Dario · officer: General Counsel and SecretaryM-Exempt16,667$0.00
Feb 19, 2026Amoroso Michael · director, officer: President and CEOM-Exempt67,797$0.00
Feb 19, 2026Amoroso Michael · director, officer: President and CEOSale20,559$3.84
Feb 19, 2026SMITH J. JEFFERSON · officer: Chief Research OfficerSale4,925$3.84
Feb 19, 2026SMITH J. JEFFERSON · officer: Chief Research OfficerM-Exempt16,667$0.00
Jan 22, 2026Kelly John Alexander · officer: Chief Financial OfficerSale15,213$4.03
Jan 22, 2026Amoroso Michael · director, officer: President and CEOM-Exempt37,069$0.00
Jan 22, 2026Amoroso Michael · director, officer: President and CEOM-Exempt8,888$0.00
Jan 22, 2026Scimeca Dario · officer: General Counsel and SecretaryM-Exempt14,908$0.00
Jan 22, 2026Scimeca Dario · officer: General Counsel and SecretarySale8,854$4.03
Jan 22, 2026Scimeca Dario · officer: General Counsel and SecretaryM-Exempt8,425$0.00
Jan 22, 2026Scimeca Dario · officer: General Counsel and SecretaryM-Exempt1,978$0.00
Jan 22, 2026Kelly John Alexander · officer: Chief Financial OfficerM-Exempt26,575$0.00
Jan 22, 2026Kelly John Alexander · officer: Chief Financial OfficerM-Exempt13,900$0.00
Jan 22, 2026Kelly John Alexander · officer: Chief Financial OfficerM-Exempt3,888$0.00
Jan 22, 2026SMITH J. JEFFERSON · officer: Chief Research OfficerM-Exempt16,219$0.00
Jan 22, 2026SMITH J. JEFFERSON · officer: Chief Research OfficerSale10,200$4.03
Institutional positioning

13F filings over the trailing two quarters

New 21Increased 24Reduced 15Sold out 76
FilerActionSharesFiled
OCTAGON CAPITAL ADVISORS LPIncreased2,236,732May 15, 2026
ABRDN PLCIncreased2,230,178Apr 29, 2026
EMPERY ASSET MANAGEMENT, LPReduced1,968,879May 8, 2026
BLEICHROEDER LPUnchanged1,662,500May 14, 2026
BOOTHBAY FUND MANAGEMENT, LLCUnchanged1,066,050May 15, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCIncreased995,371May 15, 2026
LYNX1 CAPITAL MANAGEMENT LPReduced985,113May 4, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position910,740May 15, 2026
AFFINITY ASSET ADVISORS, LLCNew Position597,946May 14, 2026
MARSHALL WACE, LLPIncreased415,671May 15, 2026
TWO SIGMA INVESTMENTS, LPIncreased307,790May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased287,090May 15, 2026
RENAISSANCE TECHNOLOGIES LLCReduced223,177May 14, 2026
BLACKROCK, INC.Increased199,761May 13, 2026
ARROWMARK COLORADO HOLDINGS LLCNew Position179,140May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 5, 2026